Cargando…
Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT-737
Regular use of aspirin after diagnosis is associated with longer survival among patients with mutated-PIK3CA colorectal cancer, but not among patients with wild-type PIK3CA cancer. In this study, we showed that clinically achievable concentrations of aspirin and ABT-737 in combination could induce a...
Autores principales: | Zhang, Chong, Shi, Jing, Mao, Shi-ying, Xu, Ya-si, Zhang, Dan, Feng, Lin-yi, Zhang, Bo, Yan, You-you, Wang, Si-cong, Pan, Jian-ping, Yang, You-ping, Lin, Neng-ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407609/ https://www.ncbi.nlm.nih.gov/pubmed/25388762 http://dx.doi.org/10.1111/jcmm.12461 |
Ejemplares similares
-
ABT-737 synergizes with Bortezomib to kill melanoma cells
por: Reuland, Steven N., et al.
Publicado: (2011) -
ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells
por: Yin, Pei, et al.
Publicado: (2016) -
The BH3-mimetic ABT-737 effectively kills acute myeloid leukemia initiating cells
por: Baev, Denis V., et al.
Publicado: (2014) -
Comparison of in vitro antileukemic activity of obatoclax and ABT-737
por: Opydo-Chanek, Małgorzata, et al.
Publicado: (2016) -
Dual role of the p38 MAPK/cPLA(2)
pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists
por: Rukoyatkina, N, et al.
Publicado: (2013)